“LL-37”的搜索结果，显示 291-300 项，共有 6975 项

1. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   ... 2 study in a selected cohort of patient with LM. Prehabilitation. Rochester, Minn. Physical activity plays an important role in reducing the adverse effects ...

2. 神经科- 临床试验- 妙佑医疗国际

   Cohort 3 includes (1) CMVpp65 absent and (2) CMVpp65 present GBM.. Patients in all subcohorts except 1.11 and 1.12 currently have unresectable advanced or ...

3. 血液科- 临床试验- 妙佑医疗国际

   This phase II trials studies how well acalabrutinib with or without obinutuzumab works in treating participants with early-stage chronic lymphocytic leukemia or ...

4. 神经科- 临床试验- 妙佑医疗国际

   The purpose of phase 2 of this trial is to evaluate the effectiveness of sequentially administering temozolomide and selinexor in recurrent glioblastoma as ...

5. 胃肠病科和肝病科- 临床试验- 妙佑医疗国际

   This phase II trial compares the impact of subcutaneous (SC) nivolumab given in an in-home setting to an in-clinic setting on cancer care and quality of ...

6. 血液科- 临床试验- 妙佑医疗国际

   This phase II trials studies how well acalabrutinib with or without obinutuzumab works in treating participants with early-stage chronic lymphocytic leukemia or ...

7. 淋巴瘤 - 医生与科室 - 妙佑医疗国际

   对抗病菌的淋巴系统中形成的癌症称为淋巴瘤。淋巴瘤的类型包括霍奇金淋巴瘤和非霍奇金淋巴瘤。

8. 血液科- 临床试验- 妙佑医疗国际

   ... II dose (RP2D of APG2575 in combination with Pomalidomide/dexamethasone (Pd) in patients with relapsed/refractory (R/R) multiple myeloma (MM), or ...

9. 神经科- 临床试验- 妙佑医疗国际

   The purpose of phase 2 of this trial is to evaluate the effectiveness of sequentially administering temozolomide and selinexor in recurrent glioblastoma as ...

10. 乳腺专科门诊- 临床试验- 妙佑医疗国际

    Scottsdale/Phoenix, Ariz. This phase II trial tests whether an exercise intervention works to improve cognitive function in breast cancer survivors. Many breast ...